MUK Nine b: OPTIMUM Treatment Protocol

Clinical trial NCT03188172 · UNKNOWN

Trial details

NCT number: NCT03188172
Sponsor: University of Leeds
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2017-09-28
Primary completion: 2025-10-01
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.